{"mainPropery":{"diseaseId":9636,"diseaseName":"Adenosarcoma of the uterus","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9636/adenosarcoma-of-the-uterus","synonyms":["Mullerian adenosarcoma of the uterus","Uterine adenosarcoma"],"synonyms-with-source":[{"name":"Mullerian adenosarcoma of the uterus"},{"name":"Uterine adenosarcoma"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C2103110"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":231,"resourceName":"Rare Cancer Alliance","abbreviation":"","address1":"1649 North Pacana Way","address2":"","address3":"","address4":"","address5":"","city":"Green Valley","state":"AZ","zip":"85614","country":"United States","phone":"520-625-5495 ","tty":"","tollFree":"","fax":"","email":"","url":"http://www.rare-cancer.org","freeText":""},{"resourceID":312,"resourceName":"CancerCare","address1":"275 Seventh Ave, Floor 22","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10001 ","country":"United States","phone":"","tty":"","tollFree":"800-813-HOPE","fax":"212-712-8495 ","email":"info@cancercare.org","url":"http://www.cancercare.org/"},{"resourceID":859,"resourceName":"The Liddy Shriver Sarcoma Initiative","abbreviation":"","address1":"17 Bethea Drive","address2":"","address3":"","address4":"","address5":"","city":"Ossining","state":"NY","zip":"10562-1620 ","country":"United States","phone":"914-762-3251 ","tty":"","tollFree":"","fax":"","email":"","url":"http://sarcomahelp.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=uterine+adenosarcoma' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Adenosarcoma of the uterus. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/uterinecancer.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/uterinesarcoma/Patient' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MESH:C538232' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6474,"questionText":"What is adenosarcoma of the uterus?","answerText":"<strong>Adenosarcoma of the uterus</strong> is a rare tumor of the uterus that typically originates in the lining of the uterus (endometrium).[5559] This type of tumor is characterized by both benign (noncancerous) and malignant components (<a href=\"http://cancerhelp.cancerresearchuk.org/type/sarcoma/about/types-of-soft-tissue-sarcomas#grade\" target=_blank>low-grade sarcoma</a>).[5559][5557] Typical symptoms in affected individuals may include abnormal vaginal bleeding, an enlarged uterus, and tissue protruding from the external os (external opening of the uterus that leads into the cavity of the cervix).[5559][5558] It is most common in post-menopausal women but can affect women of any age.[5558] Factors that may predisposed an individual to the condition include hyperestrogenemia (high blood estrogen levels), chemotherapy, or radiotherapy.[5558] Recommended treatment includes <a href=\"http://www.nlm.nih.gov/medlineplus/hysterectomy.html\" target=_blank>hysterectomy</a>, usually accompanied by bilateral salpingo-oophorectomy (removal of fallopian tubes and ovaries).[5559] Ovarian conservation is an option for reproductive age women.[5559]","dateModified":"2012-10-12T13:10:00"},"basicQuestions":[{"questionId":6475,"questionText":"What causes adenosarcoma of the uterus?","answerText":"The exact cause of adenosarcoma of the uterus is not always known. The development of these tumors has been associated with a few risk factors. Risk factors are associated with an increased risk of developing a condition; however, most people with these risk factors will never develop the condition. Factors that have reportedly been associated with development of adenosarcoma of the uterus include <a href=\"http://www.merriam-webster.com/medlineplus/hyperestrinism\" target=_blank>hyperestrinism</a> (abnormally high levels of estrogenic hormones in the body), prior chemotherapy, prior radiotherapy and tamoxifen therapy (used as an adjuvant drug for breast cancer).[5558][5560][5561]","dateModified":"2012-10-12T13:21:00","resourceClassificationName":"Cause","references":[{"referenceId":5558,"authors":"Sinha A, Phukan JP, Sengupta S, Guha P","articleTitle":"Mullerian adenosarcoma of uterus with sarcomatous overgrowth and heterologous component associated with stromal deposit in omentum: a case report and review of the literature","bookWebsiteJournalTitle":"Case Report Med","date":"2012","volume":"ePub"},{"referenceId":5560,"authors":"Tjalma WA, Michener CM","articleTitle":"Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use","bookWebsiteJournalTitle":"Eur J Obstet Gynecol Reprod Biol","date":"April 1, 2005","volume":"119(2)","pages":"253-254."},{"referenceId":5561,"authors":"Arici DS, Aker H, Yildiz E, Tasyurt A","articleTitle":"Mullerian adenosarcoma of the uterus associated with tamoxifen therapy","bookWebsiteJournalTitle":"Arch Gynecol Obstet","date":"September 2000","volume":"264(2)","pages":"105-107"}]},{"questionId":6476,"questionText":"Is adenosarcoma of the uterus inherited?","answerText":"To our knowledge, there have not been reports of familial cases of adenosarcoma of the uterus, nor have there been reports of a particular gene being linked to this specific type of tumor. Some types of uterine cancer and/or endometrial cancer are known to be associated with hereditary cancer syndromes, but we are unaware of information about an association between these cancer syndromes and uterine adenosarcoma specifically.<br><br>Individuals who are interested in learning about how their personal or family history of cancer may affect other family members should speak with an oncologist or genetics professional. These health care providers can help determine whether genetic testing for an inherited susceptibility to cancer is appropriate and/or available.","dateModified":"2012-10-12T14:09:00","resourceClassificationName":"Inheritance","references":[]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":38618,"abbreviatedInquiry":"Is radiation and/or chemotherapy considered appropriate if uterine adenosarcoma shows signs of spreading to the lymph node? Is ifosfamid an appropriate treatment? Is it available as an oral medication?","caseQuestions":[{"questionId":6816,"questionText":"Is radiation and/or chemotherapy used to treat adenosarcoma of the uterus?","answerText":"The recommended treatment option for adenosarcoma of the uterus is surgery. Total hysterectomy with <a href=\"http://www.cancer.gov/dictionary?cdrid=322852\">bilateral salpingo-oophorectomy</a> can cure this condition if it is only in the uterus. Adjuvant <a href=\"http://www.cancer.gov/dictionary?CdrID=44971\">radiation therapy</a> can help lower the chance of the tumor coming back. There is limited data and no agreement regarding the benefit of adjuvant <a href=\"http://www.cancer.gov/dictionary?CdrID=45214\">chemotherapy</a>. Chemotherapy or whole abdomen radiation therapy is used for disease that has spread into the intraperitoneal region. The chemotherapy agents consist of either <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682221.html\">doxorubicin</a> or a combination of <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a684036.html\">cisplatin</a> and ifosfamide with mesna.[5937] <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a695023.html\">Ifosfamide</a> is not available in an oral form; it is given by injection into a vein.","dateModified":"2013-03-22T13:27:00","references":[{"referenceId":5937,"authors":"Mirna Farha, Elie Hobeika, Ghada Moumneh and Anwar Nassar","articleTitle":"Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report","bookWebsiteJournalTitle":"Journal of Medical Case Reports","date":"2007","volume":"1","pages":"103","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2098769/","dateAccessed":"2013-03-22T00:00:00"}]}]},{"caseId":37930,"abbreviatedInquiry":"What is the difference between uterine adenosarcoma and uterine adenocarcinoma?&nbsp; Or are they the same thing? &nbsp;I'm trying to research this diagnosis and keep seeing these phrases used interchangeably.","caseQuestions":[{"questionId":6721,"questionText":"What is the difference between uterine adenosarcoma and uterine adenocarcinoma?","answerText":"There are two main types of <a href=\"http://www.cancer.gov/dictionary?CdrID=45333\" target=\"_blank\">cancer</a>: <a href=\"http://www.cancer.gov/dictionary?CdrID=45963\" target=\"_blank\">carcinoma</a>, which&nbsp;develops from cells that line internal organs (<a href=\"http://www.cancer.gov/dictionary?CdrID=45682\" target=\"_blank\">epithelial</a> cells), and&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=45562\" target=\"_blank\">sarcoma</a>, which&nbsp;develops from cells in muscles, nerves, or connective tissues (<a href=\"http://www.cancer.gov/dictionary?CdrID=559134\" target=\"_blank\">stromal</a> or <a href=\"http://www.cancer.gov/dictionary?CdrID=45785\" target=\"_blank\">mesenchymal</a> cells).&nbsp; An <a href=\"http://www.cancer.gov/dictionary?CdrID=46217\" target=\"_blank\">adenoma</a> is a <a href=\"http://www.cancer.gov/dictionary?CdrID=45614\" target=\"_blank\">benign</a> growth of epithelial cells and is sometimes considered the beginning of a carcinoma.&nbsp; A uterine adenosarcoma is a cancer of the uterus that is made up of both benign epithelial cells (\"adeno-\") and <a href=\"http://www.cancer.gov/dictionary?CdrID=45772\" target=\"_blank\">malignant</a>&nbsp;mesenchymal cells (\"sarcoma\").[5559]&nbsp; Uterine adenocarcinoma is a cancer of the uterus that is made up of epithelial cells only.","dateModified":"2013-01-29T23:32:00","references":[{"referenceId":5559,"authors":"Xie YP, Yao HX, Shen YM","articleTitle":"Müllerian adenosarcoma of the uterus with heterologous elements: two case reports and literature review","bookWebsiteJournalTitle":"Arch Gynecol Obstet","date":"August 2012","volume":"286(2)","pages":"537-540"}]}]},{"caseId":36865,"abbreviatedInquiry":"Is there a genetic link involved in this disease? I was recently diagnosed with it and wonder if my sister or other female relatives should be tested. Also how can I best keep up with the news? I'm not looking for technical treatises on mice but for practical information such as the effects of diet, exposure to pesticides, etc.","caseQuestions":[{"questionId":6475,"questionText":"What causes adenosarcoma of the uterus?","answerText":"The exact cause of adenosarcoma of the uterus is not always known. The development of these tumors has been associated with a few risk factors. Risk factors are associated with an increased risk of developing a condition; however, most people with these risk factors will never develop the condition. Factors that have reportedly been associated with development of adenosarcoma of the uterus include <a href=\"http://www.merriam-webster.com/medlineplus/hyperestrinism\" target=_blank>hyperestrinism</a> (abnormally high levels of estrogenic hormones in the body), prior chemotherapy, prior radiotherapy and tamoxifen therapy (used as an adjuvant drug for breast cancer).[5558][5560][5561]","dateModified":"2012-10-12T13:21:00","resourceClassificationName":"Cause","references":[{"referenceId":5558,"authors":"Sinha A, Phukan JP, Sengupta S, Guha P","articleTitle":"Mullerian adenosarcoma of uterus with sarcomatous overgrowth and heterologous component associated with stromal deposit in omentum: a case report and review of the literature","bookWebsiteJournalTitle":"Case Report Med","date":"2012","volume":"ePub"},{"referenceId":5560,"authors":"Tjalma WA, Michener CM","articleTitle":"Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use","bookWebsiteJournalTitle":"Eur J Obstet Gynecol Reprod Biol","date":"April 1, 2005","volume":"119(2)","pages":"253-254."},{"referenceId":5561,"authors":"Arici DS, Aker H, Yildiz E, Tasyurt A","articleTitle":"Mullerian adenosarcoma of the uterus associated with tamoxifen therapy","bookWebsiteJournalTitle":"Arch Gynecol Obstet","date":"September 2000","volume":"264(2)","pages":"105-107"}]},{"questionId":6476,"questionText":"Is adenosarcoma of the uterus inherited?","answerText":"To our knowledge, there have not been reports of familial cases of adenosarcoma of the uterus, nor have there been reports of a particular gene being linked to this specific type of tumor. Some types of uterine cancer and/or endometrial cancer are known to be associated with hereditary cancer syndromes, but we are unaware of information about an association between these cancer syndromes and uterine adenosarcoma specifically.<br><br>Individuals who are interested in learning about how their personal or family history of cancer may affect other family members should speak with an oncologist or genetics professional. These health care providers can help determine whether genetic testing for an inherited susceptibility to cancer is appropriate and/or available.","dateModified":"2012-10-12T14:09:00","resourceClassificationName":"Inheritance","references":[]},{"questionId":6477,"questionText":"How can I stay informed about the most up-to-date information on adenosarcoma of the uterus?","answerText":"You can find relevant articles on adenosarcoma of the uterus through <a href=\"http://www.ncbi.nlm.nih.gov/pubmed\" target=_blank>PubMed</a>, a searchable database of biomedical journal articles. Although not all of the articles are available for free online, most articles listed in PubMed have a summary available. To obtain the full article, contact a medical/university library or your local library for interlibrary loan. You can also order articles online through the publisher’s Web site. Using \"adenosarcoma of the uterus\" or \"uterine adenosarcoma\" as your search term should help you locate articles. Use the advanced search feature to narrow your search results. <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=uterine%20adenosarcoma\" target=_blank>Click here</a> to view a sample search.<br><br>The National Library of Medicine (NLM) Web site has a page for locating libraries in your area that can provide direct access to these journals (print or online). The Web page also describes how you can get these articles through interlibrary loan and Loansome Doc (an NLM document-ordering service). You can access this page at the following link <a href=\"http://nnlm.gov/members/\" target=_blank>http://nnlm.gov/members/</a>. You can also contact the NLM toll-free at 888-346-3656 to locate libraries in your area.","dateModified":"2012-10-12T14:15:00","references":[]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Adenosarcoma_of_the_uterus"}